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SITE-SATURATION MUTAGENESIS OF CRUCIAL RESIDUES IN NAD
+
 / 
NADP
+
 SPECIFICITY OF FORMATE DEHYDROGENASE FROM Candida 
methylica 
SUMMARY 
NAD
+
-dependent formate dehydrogenase (EC 1.2.1.2, FDH ) plays an important role 
in the final step of methanol oxidation pathway in methylotrophs, which catalyzes 
the oxidation of formate anion into carbondioxide, coupled with reduction of NAD
+
 
to NADH. However FDH is widely used in regeneration of NADH, it could not been 
used in NADPH regeneration for the reason that all FDHs which are already found in 
nature are highly specific to only NAD
+
 coenzyme. On the other hand NADPH 
regeneration via this enzyme  using NADP
+
 as a coenzyme is very desirable because 
of the advantages of FDH, such as its availability and low cost, a favourable 
thermodynamic equilibrium and the inertness of CO2. In order to overcome limited 
coenzyme specifity of FDH, many attempts using a rational design approach have 
been made recently. However all these mutants bind NADP
+
 very weakly and still 
show activity with NAD
+
. 
In this project, we used site saturation mutagenesis, which is a technique using a 
directed evolution approach to redesign of proteins to improve the KM of Candida 
methylica FDH for NADP
+
. Firstly, in the coenzyme binding domain, the amino acid 
residues which are responsible for the coenzyme specificity were determined by 
using Insight II (Accelrys) program on a homology model of cmFDH based on 
Pseudomonas. sp.101 and Candida boidinii FDH crystal structure. After the 
application of site saturation mutagenesis with degenerate primers to the determined 
residues D195, Y196, Q197, mutant libraries were constructed. The efficient mutants 
have been screened by using colorimetric screening assay. 27 candidates have shown 
activity towards NADP
+
 from nearly 400 screened colonies. These results reveal that, 
these residues are important in controlling the cofactor specificity of formate 
dehydrogenases, and promising for developing NADP
+
-dependent cmFDH enzyme.  
In order to determine the most active and effective candidate for the NADPH 
regeneration further kinetic assays will be applied, also further generations can be 
constructed using the active mutant as a template to improve the efficiency of the 
NADP
+
-dependent FDH for industrial usage. 
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Candida methylica FORMAT DEHİDROGENAZ’IN NAD+ / NADP+ 
SPESİFİTESİ İÇİN KRİTİK BÖLGELERİN BÖLGE SATURASYON 
MUTAGENEZİ 
ÖZET 
Metilotrofik organizmalarda metanol metabolizmasının son adımını oluşturan NAD+-
bağımlı format dehidrogenaz enzimi (EC 1.2.1.2, FDH), format iyonunun 
karbondiokside dönüşümünü katalizlerken, NAD+ molekülünün NADH‟e 
indirgenmesini sağlamaktadır. Doğada bulunan FDH‟lerin çoğunluğunun NAD+ 
koenzimine yüksek ilgisinin bulunması, FDH‟in NADH rejenerasyonunda yaygın 
olarak kullanılmasını sağlarken, NADPH rejenerasyonunda kullanımını 
kısıtlamaktadır. Bunun yanında, FDH‟in NADP+ koenzimi ile NADPH 
rejenerasyonunda kullanımı, düşük maliyeti, termodinamik kararlılığı ve son ürün 
olan karbondioksidin ortamdan kolay uzaklaştırılması gibi avantajlar sağlamaktadır. 
Bu amaçla, FDH‟in sınırlı koenzim spesifitesinin aşılması için farklı protein 
mühendisliği çalışmaları gerçekleştirilmiştir. Gerçekleştirilen rasyonel dizayn 
uygulamaları sonucunda geliştirilen mutantlar tamamen NADP+ spesifitesi 
gösterememişlerdir.  
Bu projede yönlendirilmiş evrim tekniği uygulamalarından biri olan bölge saturasyon 
mutagenez tekniği kullanılarak Candida methylica FDH‟in NADP+ spesifisitesinin 
attırılması amaçlanmıştır. Öncelikle, koenzim bağlama bölgesinde, koenzim 
spesifitesinden sorumlu amino asitler, Pseodomonas. sp.101 ve Candida boidinii 
FDH kristal yapıları baz alınarak, Insight II (Accelrys) programı ile oluşturulan 
cmFDH homoloji modeli yardımıyla belirlenmiştir. Belirlenen D195, Y196 ve Q197 
bölgelerine ait dejenere primerler ile uygulanan bölge saturasyon mutagenez 
çalışması sonucunda her bölge için mutant kütüphaneleri oluşturulmuştur. İstenen 
özelliğe sahip mutantlar kolorimetrik tarama metoduyla belirlenmiştir. Taranan 
yaklaşık 400 koloni arasında NADP+ koenzimine aktivite gösteren 27 aday mutant 
belirlenmiştir. Bu sonuçlar, belirlenen bölgelerin NAD(P)+ spesifitesinde önemli 
bölgeler olduğunu göstermiştir, ayrıca NADP+-spesifik cmFDH geliştirilmesinde 
umut verici olmuştur. Çalışmanın ileriki aşamalarında, en aktif ve etkili mutantın 
belirlenmesi için, detaylı kinetik çalışmalr uygulanacaktı. Ayrıca endüstriyel 
kullanımda daha etkili NADP+-spesifik FDH oluşturma amacıyla, aktif mutant kalıp 
kullanılarak farklı jenerasyonlar geliştirilebilir. 
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1. INTRODUCTION 
By the increasing energy consumption and because of global warming green 
processes using biocatalyst become an alternative way over traditional chemical 
catalysts  in medicine, chemical industry, food processing and in agriculture, since 
enzymes have many advantages such as; biodegradability, high selectivity like 
stereoselectivity, regioselectivity, and chemoselectivity and they produce 
enantiomerically pure products. Recently, several  industrial enzymes have been used 
for the synthesis of nearly 500 commercial products in textile, pulp and paper and 
detergent industries (65%), in food processing (25%), and in animal feed 
supplements (10%) [16, 19]. 
Industrial processes often require extreme conditions like high temperature, pressure 
and pH which require a large amount of energy to achieve. However, enzymes which 
are naturally occurring biocatalysts have some limitations for industrial usage such as 
low stability and activity at such extreme conditions. In addition, most of the 
enzymes have limited substrate and coenzyme specificity and low kcat. Several 
approaches such as nanotechnology, metabolic engineering, cellular membrane 
engineering, and protein engineering are applied to overcome the limitations and to 
increase the applications of the biocatalysts [9, 14, 19]. 
Protein engineering approaches; rational design, directed evolution and finally 
combination methods have been developed to overcome these problems and to 
optimize enzymes for specific industrial applications. 
Rational protein-design is the earliest approach which needs structural information 
and function relationship of the enzyme. In order to improve a specific property of 
the enzyme, in rational design it is important to identify the specific residues which 
are responsible for the desired property and this is provided by crystal structure data 
or data obtained from homology modeling. However, the complexity of the 
structure/function relationship in enzymes has become a factor limiting the 
application of rational design. Unlike rational design, directed evolution, which is the 
most widely used approach, does not require a detailed information of enzyme 
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structure and structure/function relation. Simply, directed evolution relies on the 
Darwinian principles of mutation and selection, which consists of the low frequency 
introduction of randomly distributed mutations by random mutagenesis or gene 
recombination, followed by selection of the mutant proteins with the desired 
properties. In directed evolution, it is important to develop a high-throughput 
screening methodology for the selection of mutants with desired properties, and thus 
this necessity limits the application of the approach. Recently, combination of the 
previous approaches has been used more efficiently in modifying industrial 
biocatalysts. Combination of random methods by using rational modification 
elements could successfully by-pass certain limitations of both directed evolution 
and rational design. Site-saturation mutagenesis (a ‘semi-rational’ approach, which 
involves all 20 amino asid possibilities randomly at specific, predetermined residues) 
which takes advantages of both rational design and directed evolution such as 
applying random mutagenesis at targeted sites in order to increase the probability of 
beneficial properties [9, 16, 27]. 
Several synthetically useful enzymes, especially oxidoreductases, are underutilized 
because of the requirement of expensive reduced nicotinamides (NADH or NADPH) 
as cofactors. Therefore, regeneration of reduced nicotinamide coenzymes 
(NAD(P)H) become very crucial for the synthesis of chiral compounds in chemical 
industry. Because of the highly costs of these coenzymes various methods such as 
chemical, electrochemical, photochemical and enzymatic methods have been 
developed for the regeneration of reduced (NAD(P)H) coenzymes. Currently, 
NAD(P)H regeneration is widely based on enzymatic methods especially  
dehydrogenase systems. Formate, glucose and phosphite dehydrogenase systems 
have been applied for the coenzyme regeneration, of them formate dehydrogenase 
(FDH) is the best and most widely used system for enzymatic NAD(P)H 
regeneration, because of the advantages of FDH. NAD
+
-dependent formate 
dehydrogenase (EC 1.2.1.2, FDH ) plays an important role in the final step of 
methanol oxidation pathway in methylotrophs, which catalyzes the oxidation of 
formate anion into carbon dioxide, coupled with reduction of NAD
+
 to NADH. 
Because of the reaction‟s simplicity, availability and low cost, a favorable 
thermodynamic equilibrium and the inertness of CO2, FDH becomes a potential 
NAD(P)H regeneration system. FDH from Candida boidinii is the only enzymatic 
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NAD(P)H regeneration system which is used industrially (tert-L-leucine production 
with FDH for NADH regeneration in Degussa Company). However, naturally 
occurring FDH‟s are highly specific to formate and NAD+, so FDHs are not efficient 
enough for NADPH regeneration. In order to overcome limited coenzyme specifity 
of FDH, many attempts using a rational design approach have been made recently. 
However, all these mutants bind NADP
+
 very weakly and still show activity with 
NAD
+
 [17, 37, 38]. 
1.1 Protein Engineering 
For thousands of years in food production via fermentation, microorganisms and 
their enzymes have been used naturally. Recently, biocatalysts (whole cells and 
enzymes) have become a great potential in various applications such as medical 
therapies, chemical, food or textile industries. However, the use of naturally 
occurring biocatalysts is hindered by the low stability or activity and lack of substrate 
or coenzyme specificity in extreme industrial conditions. To overcome the limitation 
of the natural biotocatalysts, protein engineering tools have been used to enhance the 
performance of the enzymes under non-natural industrial environments. Two distinct 
strategies of protein engineering, namely; rational design and directed evolution are 
currently available to improve stability or activity, limit substrate specificity and alter 
coenzyme specificity of the enzymes [27].  
In general, rational design is based on the structural information and the 
function/structure relation of the enzyme and changes at the predetermined residues 
are carried out by site-directed mutagenesis. In contrast, directed evolution does not 
require structural information of the enzymes. The approach is based on natural 
evolution and selection. Obtaining the desired property of the enzyme is provided 
through a high-troughput screening after random mutagenesis and/or gene 
recombination of the enzyme. Creation of mutant libraries by various directed 
evolution tools and developing a selection or screening methodology are very critical 
points of the directed evolution approach. Both of the strategies have a great 
potential in enzyme optimization for industrial applications and have distinct 
advantages, however, they also have limitations. Although, rational design enhances 
our basic knowledge about enzyme structural and catalytic mechanisms, the 
complexity of the enzyme structure/function relationship limits the application. On 
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the other hand, applications of directed evolution are hindered by creating inactive 
enzymes via random mutagenesis or gene recombination and developing an 
inefficient screening method. In addition, combination strategies which utilize both 
rational design and directed evolution could successfully by-pass the limitations of 
these strategies and enhance the properties of an enzyme [6, 27, 40]. 
 
Figure 1.1: General sheme of the protein engineering strategies. (a) Rational Design, 
(b)  Directed Evolution [40]. 
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1.1.1 Rational design 
1.1.1.1 Site-directed mutagenesis 
Rational design via site-directed mutagenesis is the earliest and most widely used 
protein engineering approach, which is based on great knowledge of 
structure/function relationship of the enzyme. 
In order to design the new properties or even new proteins, site-directed mutagenesis 
strategy aims to understand protein structure and function through the 3D protein 
structure or the homology modeling data. Several successes have been reported in the 
past, mostly about enzyme specificity and activity by site-directed mutagenesis via 
active site substitution [5,40]. Another site-directed approach, which is based on 
structural homology, has been used successfully to alter enzyme mechanism or 
substrate/cofactor specificity. For instance, introducing Ser-His-Asp into peptidyl-
prolyl isomerase resulted in an efficient proline-specific endopeptidase, [29] and 
superoxide dismutase, which is already one of the fastest known enzymes in nature 
[13], become faster  and also coenzyme specificities of  both isocitrate and 
isopropylmalate dehydrogenases altered successfully by rational design via site-
directed mutagenesis [7,8]. Although, site-directed mutagenesis displays great 
efficiency for the determination of the enzymes’ kinetic and functional properties, 
confirmation of the mutagenesis and purification of the mutant enzymes are required 
and for each round of the mutagenesis the approach might be expensive and 
impractical [6]. On the other hand, because of poorly understanding of the 
relationship between enzyme structure and function, site-directed mutagenesis does 
not always give the desired outcome [40]. 
By the increasing knowledge of 3D protein structure data and the development of 
new protein modeling tools, rational design will become a powerful complementary 
approach to directed evolution, so semi-rational approaches become more efficient 
[6,27]. 
1.1.2 Directed evolution 
Directed molecular evolution or in vitro evolution, is a general term used to describe 
the general strategy of mimicking natural evolution in the laboratory and consists of 
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various techniques for generation of protein mutants (variants) and selection of 
desirable functions [27, 43, 44]. Since it was first described in the 1970s, directed 
evolution has come out as a powerful technology and found a wide range of 
applications in industry, academia, and medicine. In the early studies of “directed 
evolution”, in vitro evolution of nucleic acids were carried out [24]. However, 
several decades later directed evolution concept was applied for in vitro engineering 
of proteins at the molecular level. More recently, directed evolution strategies have 
been applied for more complex subjects like metabolic pathways, viruses, or 
bacterial genomes. The procedure begins by determining a target biomolecule, 
metabolic pathway, or organism, and a desired phenotypic goal. A diversity of 
mutants is created  through the methods that mimic the strategies of traditional 
evolution, such as random mutagenesis and/or gene recombination. A high-
throughput screening or selection method is used to identify the individuals with the 
desired properties among the library; if necessary, selected mutants can be used as 
parents in the second round of the cycle. Because, the process is repeated until the 
phenotypic goal is achieved. Unlike natural evolution, with which the diversity can 
be achieved after thousands or even millions of years, using directed evolution a 
meaningful diversity can be created and selected in a much shorter time, like in 
several weeks.   
However, for successful directed evolution there are some requirements described as 
follows: 
i. The desired function must be physically possible. 
ii. The function must also be biologically or evolutionarily feasible. In practice, this 
means that there exists a mutational pathway to get from here to there through ever-
improving variants. 
iii. It must be possible to create libraries of mutants complex enough to contain rare 
beneficial mutations. 
iv. A rapid screen or selection that reflects the desired function is required[4] 
A range of strategies for the introduction of diversity into the starting gene(s) are 
available, and these can be broadly divided into two classes; non-recombinative 
design and recombinative design, and can range from creating libraries with as few 
as 200 variants to many tens of thousands of variants. Non-recombinative method 
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consist of in vitro random mutagenesis which have been developed to generate 
substitutions, deletions, and insertions.  Recombinative method generally consists of 
homologous or non-homologous gene recombination, which refers to the exchange 
of blocks of genetic material among two or more DNA strands [27, 40, 43]. 
1.1.2.1 Non- recombinative design 
Non-recombinative design consists of several random mutagenesis strategies, which 
are relatively simple and popular methods for generating molecular diversity via 
point mutations, and they have been developed to generate substitutions, deletions, 
and insertions. 
Early methods involved creation point mutations in a target gene through damaging 
the DNA strand, for example by treatment with chemical mutagens or by ultraviolet 
irradiation. These methods are inefficient, because they can cause substantial cell 
damage if performed in vivo. Random base pair substitutions can also be generated 
by error-prone PCR which takes advantages of the fallibility of DNA polymerase, is 
one of the simplest and most popular directed evolution tools. Also, it is possible to 
control the rate of mutagenesis in this method.  
Error-prone PCR relies on the misincorporation of nucleotides by DNA polymerase 
to generate point mutations in a gene sequence. In order to improve the efficiency, 
manganese ion can be added and also nucleotide analogs or “mutagenic 
polymerases” can be used in the PCR reaction. Because of the relative simplicity and 
versatility of error-prone PCR, it has become the most widely used mutagenesis 
strategy, but it has some limitations. The method is limited in its ability to create 
diversity at the protein level, since DNA polymerases used in PCR reactions have 
mutational biases that limit diversity. Taq polymerase and Mutazyme (Stratagene, La 
Jolla, California) will preferentially induce mutations at AT base pairs over GC base 
pairs, this tend to preserve the characteristics of the original residue. Also the 
mutation rate is low, only 1-3 mutations per 1000 base pairs in general. This may 
result in low mutation frequencies, limited diversity, and low product yield.  
Similarly, mutator strains of E. coli exploit defective DNA repair machinery and also 
create random point mutations. Random insertion and deletion (RID) can also be 
used for the diversity generation and to modify proteins [27, 40, 41, 43]. 
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The limitations of error-prone PCR mutagenesis may be overcome by saturation 
mutagenesis or sequence saturation mutagenesis (SeSaM) methods. Saturation 
mutagenesis involves the substitution of all possible amino acids randomly at a 
predetermined residue or continuous series of residues in the protein of interest. 
SeSaM, a recently described method, which is able to randomize a DNA sequence at 
every nucleotide position through use of a universal base [41, 44]. Various types of 
random mutagenesis methods are compared in Table 1.1. 
Table1.1: Comparison of non-recombinative methods [27] 
KoleMethod AAdvantages 
öğrenciler 
Disadvantages olan öğrenciler 
   
Chemical Mutagenesis Simplicity Accumulates deleterious mutations 
  Low mutation level 
Low efficiency 
Limited amino acid substitutions 
Cannot control mutation rate 
Mutator strains Simplicity Low mutation level 
Accumulates deleterious mutations 
Progeny must be transferred to  DNA 
repair-competent strain for screening 
Limited amino acid substitutions 
Cannot control mutation rate 
Error-prone PCR Simplicity Accumulates deleterious mutations 
Limited amino acid substitutions 
Polymerase bias 
Saturation Mutagenesis Simplicity 
Mutate specific site(s) in 
a gene 
Access all 20 amino 
acid 
Limited diversity generation  
Gene sequence required 
   
Sequence saturation  
Mutagenesis (SeSAM) 
Overcomes polymerase 
bias 
Target a specific 
nucleotide in a sequence 
Small fragments not mutagenized 
Four PCR reaction needed to remove 
bias 
Limited amino acid substitutions 
Random insertion/ 
Diletion (RID) 
Flexible 
Insert or remove an 
aminoacid randomly  
Acess all 20 amino acid 
Point mutations may ocur 
Time-consuming and technically 
challenging 
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1.1.2.2  Recombinative design 
Recombinative design based on homologous or non homologous gene recombination 
refers to the exchange of blocks of genetic material among two or more DNA 
strands, and is often considered the “sexual” component of evolution. Gene 
recombination, which can be divided mainly into two groups refer to; homologous 
recombination, where recombination occurs between two genes with high sequence 
identity, and non-homologous recombination, where recombination occurs between 
two DNA sequences with little or no sequence identity. 
The first in vitro homologous recombination method, DNA shuffling, was introduced 
by Stemmer in 1994 [36]. Since then, various other recombination methods have 
been developed.  
Homologous recombination strategy mimics the “sexual” recombination of genetic 
material that rearranges maternal and paternal chromosomes in germ cell DNA. Such 
recombination increases the genetic variation among a population, through this idea, 
diversity generation is targeted by gene recombination methods. 
Despite the advantages of non-recombinant methods for variant library production, 
the most significant changes in enzyme function have been created using 
recombinative methods. DNA shuffling is still the most popular method of 
recombining DNA. Shortly, DNA shuffling method involves the digestion of the 
source DNA using DNase I into random fragments, followed by reassembly of those 
fragments into a full-length gene by a primerless PCR, and final standard PCR 
reaction for the amplification of the small amount of full length gene in the presence 
of flanking primers. The fragmentation and reassembly processes cause introducing 
point mutations and these mutations add to the diversity of the mutant library 
[27,40]. 
Several years after the introduction of DNA shuffling, the method was adapted to the 
recombination of a family of related genes from various species. This method, called 
family shuffling, based on DNA shuffling method which is applied to a group of 
naturally occurring homologous genes [10]. To date, various homologous 
recombination methods have been developed, as well as non-homologous 
recombination strategies have been improved based on DNA shuffling strategy. 
  
10 
These various homologous and non-homologous recombination methods are 
compared in Table 1.2. & Table 1.3. 
Table1.2: Comparison of homologous recombination methods [27] 
KoleMethod AAdvantages öğrenciler Disadvantages olan 
öğrenciler 
DNA shuffling Robust, flexible  
Back-crossing to parent 
removes non-essential 
mutations 
Biased to crossovers in high 
homology regions 
Low crossover rate 
High percentage of parent 
Family shuffling Exploit natural diversity  
Accelerates functional enzyme 
improvement 
Biased to crossovers in high 
homology regions 
Need high sequencehomology 
in the gene family  
 High percentage of parent 
Family shuffling using 
restriction  
endonucleases 
Lower representation of parent 
in a library 
Point mutations 
Low crossover rate 
DOGS Reduced parent genes in 
shuffled library 
Lower homology required  
Can bias representation of 
parent in library 
Point mutations 
Frameshifts may occur 
Relatively low crossover rate 
RACHITT No parent genes in a shuffled 
library  
Higher rate of recombination 
Recombine genes of  low 
sequence homology 
Complex 
Requires synthesis and 
fragmentation of single-
stranded complement DNA 
RPR  Compatible with ssDNA 
DNaseI-independent  
Removes sequence bias 
Independent of template length 
Less parent DNA needed 
Need gene sequence 
Biased point mutations also 
occur 
StEP 
 
 
 
Simplicity 
 
Need high homology 
Low crossover rate 
Need tight control of PCR 
Synthetic shuffling Greater flexibility 
Increased diversity 
Chemical synthesis of many 
degenerate oligonucleotides 
Genome shuffling Improve complex, poorly 
understood phenotypes 
Adapt to multiple phenotypic 
goals 
Possibility of novel antibiotic 
resistance or pathogenicity 
Genome flexibility restricted 
by metabolic network rigidity 
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Table 1.3: Comparison of non-homologous recombination methods [27] 
KoleMethod AAdvantages öğrenciler Disadvantages olan 
öğrenciler 
   
Exon shuffling Preserves exon function Requires known intron-exon 
organization of target gene 
Limited diversity 
ITCHY Eliminate recombination bias  
Structural knowledge not 
needed 
Limited totwo parents 
Significant fraction of progeny 
out-of-frame 
Complex, labor-intensive 
THIO-ITCHY Same advantages as ITCHY  
Combines recombination and 
random mutagenesis 
Simplified ITCHY method 
Same disadvantages as ITCHY 
Incorporated dNTP analogs may 
complicate further 
experimentation  
SCRATCHY Eliminate recombination bias  
Structural knowledge not 
needed 
Limited to two parents 
Significant fraction of progeny 
out-of-frame 
Complex, labor-intensive 
DHR High recombination rate 
Eliminate recombination bias 
Synthesize numerous 
complementary oligonucleotides 
Gene seuence needed 
RM-PCR Unbiased incorporation of 
variable size DNA fragments 
Frame shifts may ocur  
Mutants may be longer or 
shorter  than expected 
SHIPREC Crossovers occur at 
structurally related sites  
Limited to two parents  
Single crossover per gene 
SISDC Recombines fragments 
without bias 
Ligates fragments in a desired 
order 
Gene sequence needed 
Must engineer endonuclease 
sites into parent genes 
Must synthesize numerous 
oligonucleotide primers 
YLBS Recombines variable size 
DNA fragments 
Shuffles large fragments such 
as exons or domains 
 
 
 
 
Non-stoichiometric 
incorporation of DNA fragments 
Frame shifts may occur 
Low product recovery 
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1.1.3 Semi-rational design 
Practical experience shows that directed evolution and rational design can produce 
remarkable changes in improving biocatalysts. However, these methods have their 
limits as discussed above. In many cases, a combination of rational design to create 
the needed structure or function and its improvement by random techniques is a 
better approach [21]. 
Recently, combination of random methods of directed evolution with elements of 
rational enzyme strategies can successfully by-pass certain limitations of both 
directed evolution and rational design (Table 1.4 ). In semi-rational approaches, pre-
determined specific residues through the basic structural or functional knowledge are 
randomized using directed evolution tools, especially saturation mutagenesis, create 
„smarter‟ libraries that gave positive results [9].  
For example, to improve the synthetic capacity of γ-humulene synthase to produce 
different sesquiterpenes saturation mutagenesis with systematic recombination 
approach inside or near the active site have been applied succefully [42]. 
Table 1.4: Comparison of the strategies of the protein engineering. 
 RATIONAL 
DESIGN 
DIRECTED 
EVOLUTION 
SEMI-RATIONAL 
DESIGN 
Knowledge of 
structure 
Required Not-required Required 
Knowledge of 
mechanism 
Required Not-required Required 
Screening and 
selection method 
Not-required Required Required 
Sensitive enzyme 
assay  
Required Not-required Not-required 
1.1.3.1 SSM: Site saturation mutagenesis 
Site saturation mutagenesis (SSM) technology is a unique method for rapid 
laboratory evolution of proteins which enables to create a library of mutants 
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containing all possible amino acid (20 naturally occurring amino acids)  changes at 
one or more pre-determined target positions in a gene sequence. 
The approach is applied at the genetic level through the use of standard DNA 
amplification by degenerate primer sets, containing either 32 or 64 codon variants for 
each amino acid residue and finally a library is constructed that contains all amino 
acid possibilities at the determined sites. 
In combination with high-throughput screening methods, the researchers have 
successfully used saturation mutagenesis to improve enzymatic properties such as 
thermostability [23,25]. 
Randomizing (mutated randomly) active-site residues by using site-saturation 
mutagenesis achieved high β- galactosidase activity (180-fold increase) in 
comparison to DNA shuffling (10-fold increase) approach and gave greater substrate 
specificity [26]. 
For developing nitrilase as a process-scale enantioselective biocatalyst is one of the 
applications of this method. Mutagenesis and screening resulted in a nitrilase variant 
with high enantiomeric excess (ee) at high substrate concentrations [12]. 
To improve catalytic properties of P2Ox from Trametes multicolor and its substrate 
specificity, the semi-rational approach was selected for the engineering. Screening 
after the saturation mutagenesis of the active site residues showed catalytic constants 
increased by up to 5.7-fold for both the sugar substrates (d-glucose and d-galactose) 
[35]. 
Also, combination of site-saturation and random mutagenesis approaches have 
improved the properties of the target biocatalysts. Several studies involving 
combination of error-prone PCR or DNA shuffling with site- saturation mutagenesis 
have created succesfull variants [9]. In the absence of structural/functional 
information, these randomizing strategies can enable primary information for the 
targeted strategies; after several rounds of random mutagenesis or DNA shuffling 
site-saturation mutagenesis can easily be applied based on the knowledge. Therefore, 
the structure-based site-saturation mutagenesis becomes a power by enhancing our 
capacity for rational design, while using advantages of random mutagenesis. And 
also, this approach becomes a powerfull tool for the protein engineering that take 
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advantages of both strategies and can by-pass the limitations of both strategies [9, 27, 
40]. 
1.2 Selection and Screening 
In protein engineering, developing an effective protocol to screen the target enzyme 
libraries with the desired properties is more critical than creation the diversity. 
Generally, directed evolution tools and semi-rational approaches need well designed 
high throughput screening methodology or direct selection methods.  
Screens for enzyme activity usually operate via detection of optical adsorption or 
fluorescence. Some of the screening methods can apply directly on agar plates, 
where changes of color are observed by direct visualization, and this screening 
process can be relatively simple. 
However, most screens involve transfer of the colonies into multi-well microplates 
which contain culture medium, growing the cells until stationary phase, and inducing 
protein expression. Cell lysis step changes according to the enzyme being 
intracellular or extracellular. If the enzyme is intracellular, extra lysis step has to be 
carried out. Finally, enzymatic activity is assayed with microplate reader. Through 
this informations, it is important to develop a sensitive, effective, and easy screening 
or selection method suitable for the target enzyme activity.  
Screening may be achieved by genetic selection, where the transformed organism 
can only survive if the desired activity is present. The system is very efficient when it 
is set up for searching for a protein function which provides a growth advantage to 
the microorganism.  
However, majority of applications of directed evolution are usually impossible using 
selection methods. Despite genetic selections have been used to great effect, many 
researchers concentrate on developing screening protocols, When selection is not 
possible, every member present in the library must be physically separated and 
individually assayed for function. This can be done either in agar plates or in 
microtiter plates, using sensitive detection methods for catalysis adapted to high-
throughput.  
Fluorogenic or chromogenic assays are widely used approaches for screening the 
properties of the target enzyme. These colorimetric or fluorometric methods are 
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notably the simplest, the most reliable, and the easiest to convert to high-throughput 
format for screening. Where products of the reaction are not directly colored or 
fluorescent, indirect assays can be used for screening of the partial activity. 
Traditional assays for purified enzymes can be scaled down for use in 96-well 
microtitre plates. Colonies can be grown directly in microtitre plates and lysed if 
necessary. Often, indirect screen which is a rapid primary screen, can be used to 
eliminate clones with zero activity, then combined with a more sensitive secondary 
screen. 
Fluorometric and colorimetric screens are the most sensitive and convenient 
approaches to use; however, they are not available for most enzymes. Also, 
instrumental approaches are avaliable for the library screening. The generic 
screening tools include HPLC, gas chromatography (GC), NMR, mass spectrometry 
(MS), and capillary array electrophoresis (CE) can be given as an example. The 
development of these assays can be achieved much faster than the chromogenic one, 
and they can also yield a much greater quantity of useful information; however, these 
assays are expensive [2, 3, 39, 40]. 
1.2.1 Colorimetric assay for NAD(P)H generation 
Commonly, dehydrogenase activity is measured directly by the production of 
NAD(P)H at 340nm, but this procedure for screening of large libraries with cell 
lysates in microplates is not suitable. The high costs of the microplates for screening 
in the UV-range, the low reproducibility of the measurements, can limit the 
efficiency of the approach.  
Therefore, colorimetric assay for the NAD(P)H generation promises to be generally 
applicable for measuring the activity of dehydrogenases.  
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Figure 1.2: Direct and indirect determination of FDH dehydrogenase activity. 
Colorimetric solid or liquid phase assays monitor NAD(P)H production indirectly by 
reduction of tetrazolium, e.g., nitroblue tetrazolium (NBT), salts to formazan dyes. 
Colorimetric assay is based on the reduction of nitroblue tetrazolium (NBT) to 
soluble formazan in the presence of phenazine methosulfate (PMS) which reacts with 
the NAD(P)H produced by dehydrogenases (Figure 1. 3.) 
If there is an active dehydrogenase in the reaction, NAD(P), and PMS, NBT is 
reduced to blue-purple formazan that, when scanned spectrophotometrically in the 
range of 400-700 nm, shows maximum absorption at ≈ 560 nm. Finally, the activity 
can be measured through blue-purple formazan at 580nm [3, 11, 22]. 
 
Figure 1.3: General scheme of the colorimetric assay for NAD(P)H generation of 
formate dehydrogenase. 
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1.3 NAD
+
-Dependent Formate Dehydrogenase 
FDHs belong to the superfamily of D-specific 2- hydroxy acid dehydrogenases, 
which combines several groups of enzymes strongly varied in quaternary structure, 
presence and type of prosthetic group, and also in substrate specificity. There are 
three families of FDH. Two of them are complex and use heavy metals such as 
molybdenium, selenium, iron, etc. The first class of FDH; complex non-NAD
+
-
dependent FDH has complex subunit structure and requires a wide variety of 
cofactors and metals. The second class of FDH; complex, soluble NAD
+
-dependent 
FDH uses NAD
+
 as a cofactor, but has a complex subunit structure like first class of 
FDH. And the third one which is the simplest and is called NAD
+
-dependent formate 
dehydrogenase; (EC 1.2.1.2, FDH ), only requires NAD
+
 as a coenzyme and does not 
contain any prosthetic groups or metal ions. NAD
+
-dependentFDH, plays an 
important role in the terminal step of the catabolism of C1 compounds in 
methylotrophs, which catalyzes the oxidation of formate anion into carbon dioxide, 
coupled with reduction of NAD
+
 to NADH (Figure 1.4.) 
The enzyme was first discovered in pea seeds more than 60 years ago, and the 
studies began in 1970s, and mostly founds in yeasts, bacteria, plants, and fungi. 
FDH, plays an important role in the energy supply of methylotrophic 
microorganisms and in the stress response of plants. In plants, enzyme localizes in 
mitochondria and its biosynthesis increases under stressful conditions.  
The clear simplicity of the substrate and the reaction makes FDH most suitable 
model for investigating the general mechanism of catalysis involving hydride ion 
transfer. In addition, FDH is one of the most promising candidates for the 
development of so-called coenzyme regeneration systems [1, 28, 31, 37, 38]. 
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Figure 1.4: General scheme of methanol metabolism in yeasts [28]. 
1.3.1 Catalytic properties of FDH 
Generally, FDHs follow Bi-Bi two-substrate order reaction with NAD
+
 as the first 
substrate. Both substrate and co-enzyme sites are pre-existed, and binding of one of 
the substrate increases the affinity of the other by 3,5 folds. The catalytic mechanism 
of this enzyme is included by a direct transfer of hydride ion from the substrate onto 
the C4-atom of the nicotinamide moiety of NAD
+
, which are present in reactions 
catalyzed by other related dehydrogenases. Majority of FDHs display Michaelis-type 
kinetics and independent functioning of the active centres. Recent studies of FDH 
from various organisms show similar kinetic properties, all the enzymes have similar 
Km values for formate (3-10 mM) and NAD
+
 (35-90 µM), and the recombinant 
FDHs are slightly different from the native enzymes. The majority of NAD
+
- 
dependent FDHs are highly specific to NAD
+
 and do not utilize NADP
+
 as a 
coenzyme, with only one exception of pseudomonas FDH displays dual coenzyme 
specificity and shows highly activity againts NADP
+
. FDHs can catalyse pH values 
between 6.0 and 9.0, and they can keep half of their activity between 50-60 °C with a 
few exceptions. Though they can work in a fairly wide range of pH, FDH is 
vulnerable to inactivation at higher temperatures [28, 37]. 
1.3.2 Structural properties of FDH 
NAD
+
-dependent FDHs do not contain any prosthetic groups or metal ions. The 
molecular masses of the enzymes from eukaryotic organisms and some 
methylotrophic bacteria range from 70 to 100 kDa [28].  NAD-dependent FDHs 
generally form homodimers and are composed of two chemically identical subunits, 
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and are highly specific to both formate and NAD
+
. Subunits consist of two domains, 
„„NAD binding domain‟‟ and „„catalytic domain‟‟ [31]. 
All FDHs can be divided into two groups; FDHs from bacteria and plants is the first 
group, and FDHs from yeasts and fungi is the other group. FDH is a highly 
conservative enzyme. The homology between enzymes of the same group is nearly 
80-85% and between two enzymes from the different groups is 50-55% and more. 
The comparison of recently known (completely and partially)  FDH sequences from 
various sources showed that nearly 20% of all residues (71 residues) are conserved. 
In addition, the catalytic amino acids, as well as the amino acids that contribute to the 
structural stability, are almost totally conserved (sequence homology of 
approximately 95%) [37]. 
Residues taking a role in the active site and co-enzyme binding sites are strictly 
conserved. 
Catalytically important amino acid residues of Pseudomonas sp. 101 FDH (psFDH) 
are Pro97, Phe98, Ile122, Asn146, (Ala/Gly)198, Gly200, Gly203, Arg284, Gln313, 
and His332, in Candida methylica FDH(cmFDH) Pro77, Phe78, Ile102, Asn118, 
Gly171, Gly173, Gly176, Arg267, Gln278 and His310 are the residues constructing 
the active site. 
The NAD binding domain (residues N119 to S313) (the residues belongs to Candida 
boidinii FDH (cbFDH)) shows a Rossmann fold structure commonly found in 
members of the dehydrogenase family. The catalytic domain is formed by the 
remaining residues and has a flavodoxin-like topology. The two domains are linked 
by two long helices, H6 and H15 [31].  
Conservative „fingerprint‟ sequence GXGXXGX17-18D(E) in the NAD+ binding 
domain is specific for the FDH structure. Negatively charged aspartic acid (D195 in 
cbFDH, D221 in psFDH) or glutamic acid at the conserved „fingerprint‟ sequence is 
critical for NAD
+
-dependent dehydrogenases, and plays an important role in 
providing the specificity to NAD
+
 versus NADP
+
. Both cbFDH and psFDH 
structures have similar dimer organization. The first glycine in fingerprint sequence 
is replaced to alanine in psFDH. Also, there is a minor influence between psFDH and 
cbFDH is the additional residue (K189) found in cbFDH which is between glycine 
triplet and the catalytic aspartate. Most of the residues involved in hydrogen bonds to 
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the cofactor are conserved and occur in similar conformation in cbFDH and apo-
psFDH. D282 and S313 make contacts to the nicotinamide ring, and R174 binds the 
phosphate linker in NAD
+
, and the adenine ring is likely to interact with H232 and 
Y196 (the residues are belonging to cbFDH). Each of the glycine residues in this 
fingerprint has a specific role, the first glycine is critical for the tightness of the turn, 
the second prevents steric hindrance of the dinucleotide and amino acid side chain of 
the protein backbone at this position, and the third is essential for proper interactions 
between the strand and helix. The third glycine allows the tight packing of helix H9 
onto strand S6, which corresponds to the first strand and its following helix in the 
cofactor-binding domain, which is in agreement with the general features of the 
three-glycine pattern of dehydrogenases. (D195 and Q197 in cbFDH interact with a 
phosphate group attached to the O29 of the NAD-ribose, additionally, Y194 and 
Y196 form a hydrophobic cluster, which could stabilize the adenine ring in a 
different position and environment [31]. Several studies for the changing coenzyme 
specifities by using site-directed mutagenesis of FDH from cmFDH, psFDH, and 
Saccharomyces cerevisiae FDH (scFDH) have shown the importance of the residues 
in the NAD
+
 specificity [18, 32, 33]. 
1.3.3 Practical applications of FDH 
1.3.3.1 NAD(P)H regeneration 
Optically active compounds are very crucial for the chemical and pharmaceutical 
industry. However, according to prescriptions of the Food and Drug Administration, 
the optical purity of all chiral compounds used as drugs has to be more than  99%. 
After these prescriptions, the enzyme applications in pharmaceutical industry are 
sharply increased. Oxidoreductases, especially, dehydrogenases can be used to 
produce optically active compounds from nonchiral ones, because dehydrogenases 
are extremely stereospecific in the transfer of hydride ion between the substrate and 
coenzyme. Therefore, these enzymes are promising for the production of optically 
active compounds with very high optical purity (99.9-99.99%). However, 
dehydrogenases are under utilized because of the requirement of expensive 
coenzymes NADH and especially of NADPH (>US$ 12,000/kg). Therefore, 
regeneration of reduced nicotinamide coenzymes (NAD(P)H) become very crucial 
for the synthesis of chiral compounds in chemical industry. Because of the high costs 
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of these coenzymes, various methods such as chemical, electrochemical, 
photochemical and enzymatic methods have been developed for regenerating 
reduced (NAD(P)H) coenzymes. Currently, NAD(P)H regeneration is widely based 
on enzymatic methods especially dehydrogenase systems. Formate, glucose and 
phosphite dehydrogenase systems have been applied for the coenzyme regeneration, 
of them formate dehydrogenase is the best and the most widely used system for 
enzymatic NAD(P)H regeneration because of the advantages of FDH [38].   
In NAD(P)H regeneration FDH provides all the criteria in the reaction; 
i. The reaction by FDH obtain 99–100% yield of the final product, because of the 
irreversibility of the raction, which provides thermodynamic pressure to shift 
equilibrium of the main reaction. 
ii. FDH exhibits a wide pH-optimum of catalytic activity (6.0– 9.0), thus FDH can be 
used in combination with any dehydrogenase that has optimum activity in this range.  
iii. The substrate of the reaction (formate-ion) is relatively cheap, and the reaction 
product, CO2, can be easily removed from the reaction mixture and does not interfere 
with the purification of the final product. 
iv. FDHs from several sources are highly stable enzymes and can be used in the 
system for a long time. 
v. FDHs are inexpensive and available, also methylotrophic bacteria or yeast can 
provide a high scale enzyme production with a comparatively low production cost.  
Therefore, FDH from Candida boidinii is the only enzymatic NAD(P)H regeneration 
system which is used industrially (tert-L-leucine production with FDH for NADH 
regeneration in Degussa Company). 
The reaction catalyzed by FDH is suitable for the system of NADH regeneration. 
However, all naturally occurring FDHs are highly specific to NAD
+
. On the other 
hand, NADPH regeneration is also critical for the chemical industry. Therefore, 
protein engineering of FDH with the aim of altering coenzyme specificity (NADP
+
 
versus NAD
+
) is become crucial [1, 17, 31, 33, 37, 38]. Recently, several approaches 
using rational design to alter the specificity of FDH from Pseudomonas sp. 101, 
Saccharomyces cerevisae and Candida methylica towards NADP
+
 have yielded 
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promising results, however FDHs are stil show high NAD
+
 activity [18, 32, 33] 
(Table 1.5 ). 
Table 1.5: Applications for changing coenzyme specifities of FDH‟s 
Aim Mutation Result Ref. 
Change 
coenzyme 
specificity of 
cmFDH from 
NAD
+
 to NADP
+
 
D195S 
cmFDH 
Decrease in coenzyme preference for 
NAD
+
 from 2.5 × 105 to 410  
[18] 
Change 
coenzyme 
specificity of 
cbFDH from 
NAD
+
 to NADP
+
 
D195S  
D195S/Y196H 
D195S/Y196H
/K356T, 
cbFDH 
 
Activity with NAD
+
 and NADP
+
  1.5 
and 0.083 U/mg, respectively   
Activity with NAD
+
 and NADP
+
  1.5 
and 0.083 U/mg, respectively   
Activity with NAD
+ 
and NADP
+ 
 1.5 
and 0.083 U/mg, respectively 
[45] 
Change 
coenzyme 
specificity of 
scFDH from 
NAD
+
 to NADP
+
 
D196A/Y197R
, scFDH 
Shift in coenzyme preference for 
NAD
+
 from > 3 × 109 to 0.43- 0.67 
resulted in NADP
+
-specific enzyme 
[33] 
Change 
coenzyme 
specificity of 
psFDH from 
NAD
+
 to NADP
+
 
psFDH T5M9-
10 
Shift in coenzyme preference for 
NAD
+
 from 2.4 × 103 to 0.29 resulted 
in NADP
+
-specific enzyme, Km
NADP+
 
is constant in pH range 6.0-7.0.  
[32] 
1.4 The Aim of the Research 
As explained above, FDH is the best candidate for the NADH regeneration system, 
because it is stable and it has relatively good activity. FDH from Candida methylica 
(cm) was cloned and overproduced
 
at the University of Bristol and purification 
processes have been improved at Department of Molecular Biology and Genetics of 
Istanbul Technical University (ITU) giving a much better yield. The one 
disadvantage of FDH is that it uses only NAD
+
 as a coenzyme. It would be also 
desirable to regenerate NADPH by using NADP
+
 as a coenzyme. Many attempts 
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using a rational design approach have been made to change the coenzyme specificity 
of FDH from NAD
+
 to NADP
+
 but all these mutants bind NADP
+
 very weakly and 
still show activity with NAD
+
.  
Here, we aim to use site saturation mutagenesis which is a technique using a directed 
evolution approach to the redesign of proteins to improve the KM of cmFDH for 
NADP
+
.  
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2.  MATERIALS AND METHODS 
2.1 Materials and Laboratory Equipments 
Equipments, media, chemicals and enzymes which were used in this study were 
given in Table 2.1, 2.2, and 2.3. 
Table 2.1: Laboratory Equipments  
Vortex Scientific Industries 
pH Meter InoLab 
Autoclaves Tuttnauer 2540ml (Switzerland) 
Magnetic Stirrer Heidolph 
Micropipettes Eppendorf,Gilson 
Orbital Shaker Incubator Biolab-Certomat (Germany) 
Microplate Shaker Incubator Ika 
Microfuge Microfuge 18 Beckman 
Centrifuge Allegra 25R Centrifuge Beckman 
UV-Visible Spectrophometer Shimadzu UV-1601 (Japan) 
Microplate Reader Perkin Elmer 
Thermocycler Biometra 
Cycle Sequencer ABI 3130 Avanti 
Electroporator Eppendorf 
Thermomixer Eppendorf 
Deep freezers ( -80 °C ) Ultra Low Sanyo 
Freezer ( -20 °C ) Biomedical Freezer Sanyo 
Refrigerator ( +4 °C ) Arçelik (Turkey) 
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Table 2.2: Media 
LB (Luria-Bertani) NaCl Carlo Erba 
Medium Tryptone Acumedia 
  Yeast Extract Acumedia 
  Agar (for solid media) Merck 
SOC Medium NaCl Carlo Erba 
Tryptone Acumedia 
Yeast Extract Acumedia 
KCl Merck 
MgCl2 Merck 
Glucose Sigma 
MM (Magic Media) E.coli Expression Medium Invitrogen 
Table 2.3: Chemicals, enzymes and used kits 
Chemicals Tris-Base Carlo Erba 
Boric Acid Merck 
EDTA BDH Laboratory 
Gelatin Merck 
NBT Sigma 
PMS Sigma 
NADP Roche 
Formate Aldrich 
IPTG Applichem 
Sodium Asetate Fluka 
Glyserol Carlo Erba 
Ampicillin Roche 
BugBuster Novagen 
Ethanol Merck 
Agarose Applichem 
Ethidium Bromide Fluka 
dNTP Roche 
Chemicals 10X Pfu Buffer Fermentas 
Tango Buffer Fermentas 
Marker 3 “ Lamda DNA” Fermentas 
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Table 2.3 (continued): Chemicals, enzymes and used kits  
Enzymes Pfu Taq Polymerase Fermentas 
PstI Fermentas 
SacI Fermentas 
DpnI Roche 
Used Kits High Pure Plasmid Isolation Kit Roche 
BigDye Terminator V3.1 Cycle Sequencing 
Kit 
Applied 
Biosystems 
2.2 Template DNA 
Plasmid DNA included of Candida methylica FDH gene, which was previously [46] 
inserted at the SacI / PstI restriction sites of the pQE-2 vector, and transformed into 
Esherichia coli host cell, was used as a template in this study. 
2.3 Methods 
2.3.1 Homology modeling 
According to the structural data and sequence analysis, the coenzyme-binding 
domain of FDHs has a classical Rossmann fold. NAD
+
-specific oxidoreductases and 
all FDHs belong to superfamily of D-specific 2-hydroxy acid dehydrogenases 
involve a conserved `fingerprint' sequence G(A)XGXXG and a conserved aspartic 
acid residue (Asp221, Asp195 and Asp196 in psFDH, cmFDH/cbFDH and scFDH 
respectively). The X-ray data for psFDH and cbFDH show that, this conserved Asp 
residue interacts with the 2‟- and 3‟-OH groups of adenosine ribose and this residue 
is a major factor of the specificity for NAD
+
[20, 31]. The catalytic Asp is located 18 
residues downstream from the Gly residue at the end of the `fingerprint' sequence in 
yeast FDHs, the bacterial and plant sequences have the conserved Asp as the 17th 
residue downstream from the end of the `fingerprint'. In addition to the conserved 
Asp196 residue, tyrosine residue in yeasts (Tyr195 in cbFDH and cmFDH, Tyr196 in 
scFDH) is replaced by Arg in bacterial and plant enzymes, and this residue is located 
at the entrance of the coenzyme binding site and it is the potential residue that 
prevents NADP
+
 binding either by unfavourable interactions or by sterically 
blocking 2‟-phosphate group binding. According to these informations, for the 
determination of the residues that are responsible for the NAD
+
 specificity, the 
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sequences of the cmFDH is compared with psFDH and cbFDH, and it shows 37% 
and 97% homology respectively. The comparison of the cmFDH and cbFDH 
sequences are shown in Figure 2.1. The conserved glycine triplet is in red color, and 
the residues responsible for the NAD
+
 binding D195, Y196, and Q197 are in green, 
blue, and yellow color respectively. 
Figure 2. 1: Sequence alignments of cbFDH and cmFDH.  
In the coenzyme binding domain, the amino acid residues, which are responsible for 
the coenzyme specificity was determined by using Insight II (Accelrys) program on a 
homology model of cmFDH based on psFDH (sp.101) and cbFDH crystal structure. 
The determined residues are; D195, Y196, and Q197,which are critical for the NAD
+ 
 
binding domain (Figure 2. 2.). 
  
29 
 
Figure 2.2: Homology model of the determined residues which are responsible for 
the  NAD
+ 
specificity of cmFDH. 
2.3.2 Library construction with site-saturation mutagenesis (SSM) 
 
2.3.2.1 Plasmid isolation 
For simultaneous purification of plasmid DNA from E. coli cultures, which were 
grown after overnight (≈12-16h) incubation in LB (Luria-Bertani) medium at 37°C, 
„High Pure Plasmid Isolation Kit‟ (Roche) was used. After overnight incubation the 
cells were harvested, and the supernatant was discarded. Bacterial pellet was 
resuspended with 250 μl suspension buffer containing RNase, then, 250 μl lysis 
buffer was added to the homogenate and incubated for 5 min at room temperature 
(RT). After incubation, lysed solution was treated with 350 μl previously chilled 
binding buffer, and incubated on ice for 5 min. The mixed solution was then 
centrifuged at 13,000 x g for 10 min at RT. The supernatant was then passed through 
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a high pure filter tube, allowing selective and efficient binding of plasmid DNA. In 
this step high pure filter tube was placed on a collection tube and centrifugation was 
performed at 13,000 x g for 1 min. The filter tube was replaced onto the collection 
tube, after discarding the flow through liquid. The filter tube was then washed with 
700 μl wash buffer. After centrifugation for 1 min flow through liquid was discarded, 
and additional centrifugation for 1 min was applied for the removal of residual wash 
buffer. Finally, the DNA filter tube was put onto a new, sterile 1,5 ml 
microcentrifuge tube, and plasmid DNA was eluted with 100 μl elution buffer after 
centrifugation for 1 min. The eluted plasmid DNA was then stored at -20°C for later 
analysis. 
2.3.2.2 Site-saturation mutagenesis polymerase chain reaction (SSM-PCR) 
Primer design 
The determined residues (D195, Y196, and Q197) in the NAD-binding domain in 
cmFDH gene were targeted for mutational analysis. For this purpose, four sets of 
primers were designed for the amplification of the whole plasmid with the 
degeneracy of the determined sites. Three sets of primers ( 195F/R, 196F/R, and 
197F/R ) were designed for single target residue, one set of primer (  195 /6 /7 F-R ) 
was designed for triple target residues. For the introduction of the mutagenesis 
degenerate primers, including all (20) amino acid posibilities were designed ( Table 
2. 1. ). Primer sequences to construct the diversity of the determined sites were 
designed using the Primer3 software (available online at http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). 
 
 
 
 
 
 
 
 
 
 
  
31 
 
Table 2.4: Degenerate oligonucleotide primer sets of the determined residues for the 
site-saturation mutagenesis PCR 
Primers  Sequence  
195 F caaaagaattattatactacNNKtatcaagctttacc  
195 R ggtaaagcttgataMNNgtagtataataattcttttg  
196 F gaattattatactacgatNNKcaagctttacc  
196 R ggtaaagcttgMNNatcgtagtataataattc  
197 F ctacgattatNNKgctttaccaaaagaagc  
197 R gcttcttttggtaaagcMNNataatcgtag  
195 /6 /7 F 
195 /6 /7 R 
gaattattatactacNNKNNKNNKgctttaccaaaagaagc  
gcttcttttggtaaagcMNNMNNMNNgtagtataataattc  
N= A, T, G, C K= G or T; M= C or A. 
SSM-PCR 
Site-saturation polymerase chain reaction was used to amplify the whole plasmid 
DNA for introduction of diversity to predetermined sites of the cmFDH by using 
degenerate primers. For this purpose, the isolated plasmid DNAs of the study were 
used as templates. The mixture was used for the SSM-PCR. ( Table 2. 2. ) 
Table 2.5: Site-saturation PCR mix  
Ingredient Stock Conct. Volume Final Conct. 
PfuTaq Buffer 10X 5μl 1X 
dNTP mix 10mM 1.5 μl 0.3mM 
Forward Primer  10 μM 1 μl 0.2 μM 
Reverse Primer  10 μM 1 μl 0.2 μM 
Taq Polymerase  5U/ μl 0.5 μl 2.5 U 
dH2O  - 40 μl - 
Template DNA  50ng / μl 1 μl 1ng 
TOTAL 50 μl 
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PCR conditions 
Table 2.6: Site-saturation PCR cycle conditions  
Cycle Number  Degree  Time  Phase  
1 95 °C  2 min Initial Denaturation  
35 95 °C  2 min Denaturation  
50 °C  2 min Annealing  
72 °C  8 min Elongation  
1 72 °C  10 min Final Extension  
1 4°C  ∞  Final Hold  
 
2.3.2.3 Agarose gel electrophoresis 
Due to the size of the PCR products being nearly 6 kb (4800 bp PQE-2 plasmid + 
1094 bp cmFDH gene ), 1% agarose gels were used in this study. For this purpose, 
agarose gels were composed of 0,40 mg agarose, 2 μl (0,4 μg/ml) of ethidium 
bromide, and 40 ml of 1X TBE buffer, which is diluted from 10X stock TBE. 5 μl of 
PCR product was mixed with 1 μl 6X loading dye (Fermentas) and loaded into the 
wells. Marker 3 „„Lambda DNA / EcoRI+ Hind III ‟‟(Fermentas) was used as DNA 
marker. The gels were run in 1X TBE buffer, at 90V with power supply, for at least 
30 minutes. The gels are observed under UV light. 
2.3.2.4  DpnI digestion 
After amplification of the plasmid DNA, the PCR product was digested with 10 units 
of DpnI (Roche) for 4 hours at 37°C.  DpnI endonuclease recognises and cleaves the 
methylated adenine sites, and  dam
+ 
strains are suitable for this restriction (Figure 2. 
3.). Therefore, restriction of the PCR products provide the elimination of the  
ancestral dam
+ 
 templates with no mutation. Our templates, were also dam
+
 , and for 
further studies with mutated plasmids, the  ancestral plasmids with no mutation were 
eliminated by DpnI digestion. 
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Figure 2.3: Restriction sites of  DpnI endonuclease 
2.3.3 Competent cell preparation 
For transformation of the mutagenesis products, BL21 electrocompetent cells were 
prepared in the laboratory. For the starting material commercial BL21 cells ( New 
England Biolabs ) were used. The preparation procedure was summarized in Figure 
2. 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Scheme of the electrocompetent cell preparation prosedure 
Transfer 5μl BL21 stock culture to the flasks within 10 ml LB 
medium 
Overnight incubation at 37 °C on the orbital shaker 
Inoculation of 1 ml starter culture to the flasks 100 ml LB medium 
Incubation at 37 °C until OD600 reach to 0,6 
Incubation on ice for 30 minutes 
Centrifugation 2500 rpm for 15 min.at +4 °C 
Resuspension pellets with 40 ml cold, sterile dH2O 
Centrifugation 2500 rpm for 15 min.at +4 °C 
 
Resuspension pellets with 20 ml cold, sterile dH2O 
 
Centrifugation 2500 rpm for 15 min.at +4 °C 
 
Resuspension pellets with 1 ml 10% glycerol 
Aliquot 50μl of solution into sterile microfuge tubes 
Liquid Nitrogen Bath & stored at -80 °C 
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2.3.4 Transformation 
After digestion with DpnI, PCR products were transformed directly to previously 
prepared BL21 electrocompetent cells. For this purpose, 3 μl of PCR product was 
added into 50 μl BL21 electrocompetent cell, cells were then transferred to the 
electroporator cuvettes. After the electroporation, 250 μl S.O.C medium was 
immediately added to the cells, the solution was then transfered into tubes, and they 
were shaken and incubated for at least 1 hour at 37°C. Finally, after spreading 50 - 
100 μl from each transformation on a prewarmed LB agar plate including (100 
μg/ml) ampicillin, they were incubated overnight at 37°C.  
2.3.5 Mutation confirmation 
For the mutation confirmation, several colonies were picked randomly and cultured 
through overnight incubation at 37°C, then plasmid DNA was isolated as mentioned 
in section 2.3.1.  
2.3.5.1 PstI / SacI restriction 
For the mutation confirmation, firstly, isolated plasmid DNA was restricted by 
SacI/PstI restriction enzymes, in order to confirm cmFDH gene if inserted into 
SacI/PstI restriction sites of the PQE-2 vector. For this purpose, 10 μl of plasmid 
DNA was digested with SacI: PstI (1:1 units) for 2 hours at 37°C. 
2.3.5.2 Sequence analysis 
Sequence analysis was applied to the isolated plasmid DNA from the transformed 
colonies which were picked randomly in order to confirm the mutation. Sequence 
analysis composed of sequence PCR and sequence PCR product purification.  
PCR conditions 
For the sequence analysis, sequence PCR was applied by using BigDye Terminator 
V 3.1 Cycle Sequencing Kit (Applied Biosystems) with the primer 488F (5‟-
CTCTGTTGCTGAACACGTTC-3‟). The ingredients and the conditions of the 
sequence PCR are shown in Table 2.4. and 2.5. 
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Table 2.7: Sequence PCR  
Ingredient Volume 
5X Buffer 2 μl 
RR-100 2 μl 
Primer 1 μl 
Template 1 μl 
dH2O 4 μl 
Total 10 μl 
Table 2. 8: Sequence PCR Conditions 
Cycle Number  Degree  Time  Phase  
1 96 °C  1 min Initial Denaturation  
30 96 °C  10 sec Denaturation  
50 °C  5 sec Annealing  
60 °C  4 min Elongation  
1 4°C  ∞  Final Hold  
PCR product purification 
For the sequence analysis, PCR products were purified by the following procedure. 
Each 10 μl PCR product was transfered to 1,5 ml microfuge tubes, and 4 μl mixture 
of 3M Sodium Acetate:125mM EDTA and 50 μl 100% ethanol were added into the 
PCR products. After incubation at RT for 15 minutes, they were centrifugated at 
13.000 x rpm for 15 minutes. The supernatant was discarded, then 70 μl 70% ethanol 
were added to the tubes and mixed well, and centrifugated at 13.000 x rpm for 15 
minutes. After discarding the supernatant, the products were washed with 70 μl 70% 
ethanol, and centrifugated at 13.000 x rpm for 15 minutes. Finally, all supernatant 
was discarded and residual ethanol was removed, then the DNA was resuspended 
with 20 μl formamide and denaturated at 94 °C for a few minutes. The purified DNA 
was then analysed with cycle sequencer (ABI 3130 Avanti). 
2.3.6 Library construction (stock culture preparation) 
After site-saturation mutagenesis, transformed colonies, nearly 100 individual 
colonies from each library (D195, Y196, Q197, and D195/Y196/Q197) were picked 
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and transfered into 96-well microplates which included 100 μl Magic Media (MM) 
„E.coli Expression Medium‟ (Invitrogen) with ampicilin. MM is a commercial media 
which provides E. coli expression without IPTG induction. The master plates then 
were grown at 37°C for 18 hours, and were stored as 20% glycerol stocks frozen at -
80°C for the further studies. 
2.3.7 Screening with colorimetric assay 
 
2.3.7.1  Lysate preparation  
For screening the FDH activity, mutated individuals in the master plates of the 
libraries were transferred as triple replicates to the 96-deepwell microplates including 
1,5 ml MM with ampicilin. Also each plate was included triple replication of the 
medium without any inoculation, PQE-2 vector without FDH insertion, and PQE-2 
vector with wild type FDH as negative controls. After the deepwell plates were 
grown at 37°C for 22 hours, cells were harvested by centrifugation at 4000 x g for 20 
minutes, and the medium was removed.  The pellets then, were resuspended with 50 
μl BugBuster (Novagen), and the plates were shaken at RT for 20 minutes. After 
incubation the plates were centrifugated at 4000 x g for 20 minutes, and then the 
lysates as supernatant were removed to new plates for the screening assays. 
2.3.7.2 Activity measurement 
For library screening, colorimetric assay was applied. Each 200 μl reaction contained 
20 μl of lysate, 30 μl of dilution buffer ( 50 mM Tris-HCl [pH 8.0] and 0,13 % 
gelatin), and 150 μl reaction buffer ( 300 μM NADP, 300 μM formate, 300 μM NBT, 
and 30 μM PMS in dilution buffer). The reaction was started by adding lysate to the 
reaction solution, and then the kinetics were monitored at OD580 for the first 3 
minutes. Finally, the reaction was observed in blue-purple color. The average of the 
triple replications of each mutant was analysed, and the candidate mutants with 
activity towards NADP
+
 were determined. All these studies are summarized in 
Figure 2.5. 
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Figure 2.5: Summary of the experimental study of the site-saturation mutagenesis. 
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3.  RESULTS AND DISCUSSION 
3.1 Site-Saturation Mutagenesis Amplification 
For the library construction of the determined NAD
+
 binding residues, the diversity 
was set up with site-saturation mutagenesis which was mentioned in section 2.3.2. 
The amplified PCR products were then controlled in agarose gel electrophoresis, 
which is shown in Figure 3. 1. 
 
Figure 3.1: Agarose Gel Electrophoresis of determined residues in NAD
+ 
binding 
region. M; Marker 3( λ DNA/ EcoRI+ Hind III (Fermentas)); 21226 bp, 
5184 bp, 4973 bp, 4268bp, 3530 bp, 2027 bp, 1904 bp, 1584 bp, 1375 
bp, 947 bp, 831 bp, 564 bp., 195,196,197, and 195/6/7; are the PCR 
products of the mutated regions respectively. ≈ 6kb PCR products (≈ 
5kb vector + ≈ 1kb the insert cmFDH) are shown respectively. 
3.2 Transformation 
The amplified templates with all amino acid possibilities at determined sites (D195, 
Y196, Q197, and D195/Y196/Q197) were transformed into BL21 electrocompetent 
cells. After transformation, 4 libraries D195, Y196, Q197, and D195/Y196/Q197 
according to the mutated regions were constructed with many individuals (Figure 
3.2, 3.3, 3.4, and 3.5). 
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Figure 3.2: Library of D195                           Figure 3.3: Library of Y196 
Figure 3.4: Library of Q197             Figure 3.5: Library of D195/Y196/Q197 
3.3 Mutation Confirmation 
For the mutation confirmation, a few transformed mutants were picked, and analysed 
as mentioned in section 2. 6.  SacI/PstI restriction was applied for the control of the 
insert cmFDH, and sequence analysis was applied for the control of the amino acid 
changes. 
3.3.1 SacI/PstI restriction 
Agarose gel electrophoresis of SacI/PstI restriction is shown in Figure 3.6. 
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Figure 3.6: SacI/PstI restriction of the template DNA. M; Marker 3( λ DNA/ EcoRI+ 
Hind III (Fermentas)); 21226 bp, 5184 bp, 4973 bp, 4268bp, 3530 bp, 
2027 bp, 1904 bp, 1584 bp, 1375 bp, 947 bp, 831 bp, 564 bp., 
195,196,197, and 195/6/7; are the PCR products of the mutated regions 
respectively. ≈ 5kb vector, and ≈ 1kb the insert cmFDH are shown 
respectively. 
3.3.2 Sequence analysis 
The comparison of the sequences of the mutated individuals and the orgjinal cmFDH 
sequence is shown in Figure 3.7., the amino acid changes of the different residues are 
shown in Table 3.1. 
 
Figure 3.7: Sequences allignmets of the libraries ( D195, Y196, Q197, and 
D195/Y196/Q197) respectively. The original residues are in blue color, 
the amino acid changes are shown in red. 
 
pQE-2 vector 
(4800 bp) 
cmFDH  
(1094 bp) 
  
42 
Table 3.1: Amino acid changes in the determined residues (D195,Y196, Q197, and 
D195/Y196/Q197) 
Amino acid residues Amino acid Changes 
D195 (Aspartic Acid) T  R L I 
Y196 (Tyrosine) V F A H 
Q197 ( Glutamine) P V 
D195/Y196/Q197 V/R/R A/G/A R/R/Q G/L/A 
3.4 Screening with Colorimetric Assay 
For screening the desired mutant in the libraries, activities of the individuals were 
detected indirectly by using colorimetric assay ( NBT-PMS assay), as mentioned in 
section 2.8.  Nearly 100 colonies of each library were screened at 580nm for 3 
minutes. The increments of the optic density  of the mutants and the negative 
controls are shown in Table 3.2. In the library of D195 ≈ 20 individuals, in the 
library of Y196 ≈ 30 individuals, in the library of Q197 ≈ 25 individuals, and in the 
library of (which all three residues were  mutated) D195/Y196/Q197 ≈ 20 
individuals are positive mutants, the rest of the individuals have shown no activity 
towards the NADP
+
. The assay plates and the graphics of the mutants with higher 
activity compared with negative controls are shown in Figure 3.8- 3.15. The amino 
acid changes of some active mutants which were determined by cycle sequencing as 
mentioned in section 2.2.5, were shown in Table 3.3. 
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Table 3.2: Average OD of the mutants of D195, Y196, Q197, and D195/Y196/Q197 
Libraries 
Examples 
D195 
Average 
OD 
Examples 
Y196 
Average 
OD 
Examples 
Q197 
Average 
OD 
Examples 
195/6/7 
Average 
OD 
Blank 0,000 Blank 
0,000 
Blank 
-0,001 
Blank -0,001 
 
PQE-2 
without 
FDH 
-0,001 PQE-2 
without 
FDH -0,001 
PQE-2 
without 
FDH 0,000 
PQE-2 
without 
FDH 
0,000 
 
PQE-2 with 
wild type 
FDH 
0,001 PQE-2 with 
wild type 
FDH 0,000 
PQE-2 with 
wild type 
FDH -0,001 
PQE-2 with 
wild type 
FDH 
-0,024 
 
M1 -0,034 M1 -0,033 M1 0,014 M1 -0,002 
M2 0,008 M2 -0,014 M2 0,021 M2 0,013 
M3 0,004 M3 -0,001 M3 0,035 M3 0,015 
M4 -0,010 M4 -0,001 M4 -0,032 M4 0,017 
M5 -0,019 M5 0,012 M5 0,007 M5 0,005 
M6 0,005 M6 0,001 M6 0,012 M6 -0,004 
M7 0,004 M7 -0,003 M7 -0,012 M7 -0,003 
M8 -0,001 M8 -0,087 M8 0,028 M8 -0,004 
M9 0,001 M9 -0,144 M9 0,016 M9 -0,029 
M10 0,035 M10 -0,036 M10 0,013 M10 0,022 
M11 0,006 M11 -0,033 M11 -0,112 M11 -0,018 
M12 0,006 M12 -0,018 M12 0,004 M12 -0,011 
M13 0,005 M13 -0,051 M13 0,016 M13 -0,063 
M14 -0,008 M14 -0,007 M14 -0,075 M14 0,010 
M15 0,008 M15 -0,023 M15 -0,049 M15 0,007 
M16 0,005 M16 -0,002 M16 0,009 M16 0,008 
M17 0,003 M17 -0,005 M17 0,032 M17 -0,005 
M18 0,005 M18 0,007 M18 0,003 M18 -0,004 
M19 0,007 M19 -0,004 M19 0,069 M19 0,026 
M20 0,005 M20 0,021 M20 0,013 M20 0,001 
M21 0,000 M21 -0,003 M21 0,019 M21 -0,009 
M22 -0,059 M22 -0,117 M22 -0,014 M22 -0,005 
M23 -0,011 M23 -0,142 M23 -0,035 M23 0,055 
M24 -0,001 M24 0,007 M24 0,008 M24 0,052 
M25 -0,082 M25 -0,002 M25 0,002 M25 0,001 
M26 0,004 M26 0,003 M26 0,000 M26 -0,024 
M27 0,007 M27 0,019 M27 -0,078 M27 0,006 
M28 0,008 M28 0,002 M28 0,056 M28 0,059 
M29 0,091 M29 -0,010 M29 -0,052 M29 0,021 
M30 0,002 M30 -0,002 M30 -0,108 M30 0,008 
M31 -0,050 M31 0,002 M31 0,012 M31 0,000 
M32 0,015 M32 0,008 M32 0,010 M32 0,013 
M33 0,015 M33 0,000 M33 0,013 M33 -0,050 
M34 0,014 M34 -0,038 M34 0,016 M34 0,008 
M35 -0,028 M35 0,008 M35 -0,069 M35 0,005 
M36 -0,020 M36 -0,031 M36 -0,101 M36 0,004 
M37 0,000 M37 -0,016 M37 0,031 M37 0,027 
M38 0,000 M38 -0,006 M38 0,071 M38 0,022 
M39 -0,007 M39 0,009 M39 0,011 M39 -0,027 
M40 -0,019 M40 -0,035 M40 -0,060 M40 -0,004 
M41 0,001 M41 0,017 M41 0,013 M41 0,046 
M42 0,019 M42 0,013 M42 0,020 M42 0,019 
M43 0,010 M43 0,011 M43 0,034 M43 -0,014 
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Table 3.2 (continued): Average OD of the mutants of D195, Y196, Q197, and 
D195/Y196/Q197 Libraries  
M44 0,004 M44 0,012 M44 0,007 M44 -0,044 
M45 0,010 M45 0,008 M45 0,015 M45 0,055 
M46 0,011 M46 0,020 M46 0,035 M46 0,003 
M47 0,025 M47 0,012 M47 0,022 M47 -0,080 
M48 0,038 M48 0,011 M48 -0,003 M48 0,005 
M49 0,020 M49 0,017 M49 0,014 M49 -0,034 
M50 0,020 M50 0,025 M50 0,026 M50 0,026 
M51 0,036 M51 -0,027 M51 0,002 M51 -0,007 
M52 0,028 M52 0,020 M52 -0,008 M52 0,005 
M53 0,064 M53 0,029 M53 -0,024 M53 0,039 
M54 0,014 M54 -0,028 M54 -0,043 M54 0,019 
M55 0,047 M55 0,013 M55 -0,018 M55 -0,065 
M56 0,044 M56 0,011 M56 -0,005 M56 0,001 
M57 0,045 M57 0,028 M57 0,010 M57 0,002 
M58 0,031 M58 0,008 M58 -0,051 M58 0,016 
M59 0,013 M59 0,039 M59 0,020 M59 -0,030 
M60 -0,022 M60 -0,046 M60 -0,012 M60 -0,014 
M61 0,016 M61 0,004 M61 0,012 M61 0,028 
M62 0,008 M62 0,039 M62 -0,025 M62 0,011 
M63 0,003 M63 0,036 M63 0,004 M63 0,017 
M64 -0,038 M64 -0,033 M64 -0,023 M64 -0,035 
M65 0,012 M65 0,028 M65 0,002 M65 -0,054 
M66 0,004 M66 0,043 M66 0,006 M66 0,016 
M67 0,005 M67 0,044 M67 0,008 M67 0,037 
M68 0,003 M68 0,026 M68 0,004 M68 -0,009 
M69 0,025 M69 0,031 M69 0,011 M69 -0,047 
M70 0,004 M70 0,041 M70 0,029 M70 -0,011 
M71 0,001 M71 0,039 M71 0,070 M71 -0,016 
M72 0,006 M72 0,011 M72 0,009 M72 -0,012 
M73 0,002 M73 0,022 M73 0,013 M73 0,051 
M74 0,004 M74 0,032 M74 0,062 M74 0,018 
M75 0,016 M75 0,029 M75 0,049 M75 0,013 
M76 0,012 M76 -0,032 M76 0,010 M76 0,017 
M77 0,002 M77 -0,025 M77 -0,031 M77 0,014 
M78 -0,024 M78 0,040 M78 0,020 M78 0,062 
M79 -0,011 M79 0,053 M79 -0,047 M79 0,069 
M80 0,035 M80 0,026 M80 -0,075 M80 0,031 
M81 0,021 M81 0,020 M81 0,047 M81 0,011 
M82 0,013 M82 0,027 M82 0,019 M82 0,010 
M83 0,011 M83 0,039 M83 0,036 M83 0,010 
M84 0,022 M84 0,004 M84 0,012 M84 -0,043 
M85 0,011 M85 0,030 M85 0,035 M85 -0,077 
M86 0,010 M86 0,044 M86 0,029 M86 0,006 
M87 -0,046 M87 0,053 M87 0,014 M87 0,020 
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 Figure 3.8: NBT-PMS assay reaction of the D195. The first 9 wells are the negative 
controls (the first triplet is blank, the second triplet is empty PQE-2, the 
third triplet is  PQE-2 with cmFDH), and the rest of them are mutants. 
 
 
Figure 3.9: Graphic of the D195 screening assay. The negative controls and the 
positive mutants are compared. 
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Figure 3.10: NBT-PMS assay reaction of the Y196. The first 9 wells are the 
negative controls (the first triplet is blank, the second triplet is empty 
PQE-2, the third triplet is  PQE-2 with cmFDH), and the rest of them 
are mutants. 
 
 
Figure 3.11: Graphic of the Y196 screening assay. The negative controls and the 
positive mutants are compared. 
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Figure 3.12: NBT-PMS assay reaction of the Q197. The first 9 wells are the negative 
controls (the first triplet is blank, the second triplet is empty PQE-2, the 
third triplet is  PQE-2 with cmFDH), and the rest of them are mutants. 
 
 
Figure 3.13: Graphic of the Q197 screening assay. The negative controls and the   
positive mutants are compared. 
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Figure 3.14:  NBT-PMS assay reaction of the D195/Y196/Q197. The first 9 wells 
are the negative controls (the first triplet is blank, the second triplet is 
empty PQE-2, the third triplet is  PQE-2 with cmFDH), and the rest of 
them are mutants. 
 
 
Figure 3.15: Graphic of the D195/Y196/Q197 screening assay. The negative 
controls and the positive mutants are compared. 
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Table 3.3: Amino acid changes of the active mutants in the determined residues 
(D195,Y196, Q197, and D195/Y196/Q197). 
Amino acid residues Names of mutants Amino acid changes 
D195 (Aspartic Acid) 195/M29 D195S 
195/M53 D195F 
195/M55 D195G 
195/M56 D195C 
Y196 (Tyrosine) 196/M66 Y196W 
196/M70 Y196V 
196/M86 Y196H 
Q197 ( Glutamine) 197/M19 Q197V 
 197/M28 Q197M 
 197/M38 Q197P 
 197/M75 Q197A 
D195/Y196/Q197 567/M41 D195Y/Y196C/Q197R 
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4. CONCLUSION  
NAD
+
-dependent formate dehydrogenase (EC 1.2.1.2, FDH) is the last enzyme in the 
metabolism of methanol in methylotrophs and catalyzes the oxidation of the formate 
anion into carbon dioxide concomitant with
 
the reduction of NAD
+
 to NADH. One 
crucial role of this enzyme in industrial redox chemistry is to regenerate NADH from 
NAD
+
- and formate. The amino acid sequences of FDHs from aerobic to anaerobic 
organisms have been reported and there are crystal structures of FDHs from the 
bacterium Pseudomonas sp 101 (ps. sp101) and Candida boidinii (cb). An 
investigation of FDHs led to the selection of Candida species FDH as the best 
candidate for the NADH regeneration system, because it is stable and it has relatively 
good activity. FDH from Candida methylica (cm) was cloned and overproduced
 
at 
the University of Bristol and purification processes have been improved at 
Department of Molecular Biology and Genetics of Istanbul Technical University 
(ITU) giving a much better yield. The one disadvantage of FDH is that it uses only 
NAD
+
 as a coenzyme. It would be also desirable to regenerate NADPH by using 
NADP
+
 as a coenzyme. Many attempts using a rational design approach have been 
made to change the coenzyme specificity of FDH from NAD
+
 to NADP
+
 but all these 
mutants bind NADP
+
 very weakly and still show activity with NAD
+
.  
In this project, we used site saturation mutagenesis which is a technique using a 
directed evolution approach to redesign proteins to improve the KM of cmFDH for 
NADP
+
. Firstly, in the coenzyme binding domain the amino acid residues which are 
responsible for the coenzyme specificity were determined by using Insight II 
(Accelrys) program on a homology model of cmFDH based on ps. sp.101 and cb. 
After the application of site saturation mutagenesis with degenerate primers to the 
determined residues D195, Y196, Q197, mutant libraries were constructed. The 
efficient mutants have been screened by using suitable screening assays in 96-well 
microplates. 
According to the relative results of the colorimetric assay we obtained a set of 
positive mutants that show clearly improved NADP
+
 specificity compared to the 
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wild-type. Following the production of both wild type and mutant FDHs, kinetic 
studies of positive mutants will be performed. Also further site-saturation 
mutagenesis can be applied in order to construct further generations of the efficient 
mutants which can be used as  templates to improve the properties of the NADP
+
-
specific cmFDH. 
In conclusion, site-saturation mutagenesis of crucial residues in NAD(P) specificity, 
D195, Y196 and Q197 from cmFDH coupled with screening by colorimetric assay 
has resulted in  promising candidate mutants with high NADP
+ 
activity. 27 
candidates have shown activity towards NADP
+
 from nearly 400 screened colonies. 
These results reveal that, these residues are important in controlling the cofactor 
specificity of formate dehydrogenases, and promising for developing NADP
+
-
dependent cmFDH enzyme.  
Further kinetic assays will be applied in order to determine the most active and 
effective candidate for the NADPH regeneration, also further generations can be 
constructed using the active mutant as a template to improve the efficiency of the 
NADP
+
-dependent FDH for industrial usage. 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
53 
 
REFERENCES 
[1] Andreadeli, A., Platis, D., Tishkov, V. I., Popov, V. O., Labrou, N. E., 2008. 
Structure-guided alteration of coenzyme specificity of formate 
dehydrogenase by saturation mutagenesis to enable efficient 
utilization of NADP
+
, FEBS Journal  
[2] Antikainen, N. M., Martin, S. F., 2005: Altering protein specificity: techniques 
and applications, Bioorganic & Medicinal Chemistry, 13,  2701–
2716 
[3] Arnold, F. H., Georgiou, G., 2003. DirectedEnzyme Evolution: Screening and 
Selection Methods, Humana Press Inc., Totowa, NJ  
[4] Arnold, F.H., 2007. Directed enzyme evolution, 
http://www.che.caltech.edu/groups/fha/directed_evolution.html  
[5] Cedrone, F., Ménez, A., Quéméneur, E., 2000. Tailoring new enzyme functions 
by rational redesign, Current Opinion in Structural Biology, 10, 
405–410  
[6] Chen, R., 2001. Enzyme engineering: rational redesign versus directed evolution, 
Trends in Biotechnology, 19, 13-14  
[7] Chen,R.,  Greer, A., Dean, A. M., 1996. Redesigning secondary structure to 
invert coenzyme specificity in isopropylmalate dehydrogenase,  
Proc. Natl. Acad.Sci. U. S. A., 93, 12171–12176  
[8] Chen, R., 1999. A general strategy for enzyme engineering, Trends Biotechnol., 
17, 344–345  
[9] Chica, R. A., Doucet, N., Pelletier, J. N., 2005. Semi-rational approaches to 
engineering enzyme activity: combining the benefits of directed 
evolution and rational design, Current Opinion in Biotechnology, 
16, 378–384  
[10] Crameri, A., Raillard, S. A., Bermudez, E., Stemmer, W. P., 1998. DNA 
shuffling of a family of genes from diverse species accelerates 
directed evolution, Nature, 391, 288-291  
[11] Debnam, P. M., Shearer, G., 1997. Colorimetric Assay for Substrates of 
NADP
+
 -Dependent Dehydrogenases Based on Reduction of a 
Tetrazolium Dye to Its Soluble Formazan, Analytical Biochemistry, 
250, 253-255    
[12] DeSantis, G., Wong, K., Farwell, B., Chatman, K., Zhu, Z., Tomlinson, G., 
Huang, H., Tan, X., Bibbs, L., Chen, P., 2003. Creation of a 
productive, highly enantioselective nitrilase through gene site 
saturation mutagenesis (GSSM),  J. Am. Chem. Soc., 125, 11476-
11477   
  
54 
[13] Getzoff, E. D.,  Cabelli, D. E., Fisher, C. L.,  Parge, H. E.,  Viezzoli, M. S., 
Banci, L., Hallewell, R. A., 1992. Faster superoxide dismutase 
mutants designed by enhancing electrostatic guidance, Nature, 358, 
347–351    
[14] Hibbert, E. G., Baganz, F., Hailes, H. C., Ward, J. M., Lye, G. J., Woodley, 
J. M., Dalby, P.A., Directed evolution of biocatalytic processes, 
2005. Biomolecular Engineering, 22, 11–19   
[15] Hurley, J. H., Chen, R., Dean, A.  M., 1996. Determinants of cofactor 
specificity in isocitrate dehyrdrogenase: structure of an engineered 
NADP
+→ NAD+ specificity-reversal mutant,  Biochemistry, 35, 
5670–5678   
[16] Johannes, T. W., Zhao, H., 2006. Directed evolution of enzymes and 
biosynthetic pathways, Current Opinion in Microbiology, 9, 261–
267  
[17] Johannes, T. W., Woodyer, R. D.,  Zhao, H., 2007. Efficient Regeneration of 
NADPH Using an Engineered Phosphite Dehydrogenase, 
Biotechnol. Bioeng., 96, 18–26       
[18] Karaguler, N. G., Sessions, R.B., Clarke, A. R., Holbrook, J. J., 2001. A 
single mutation in the NAD-specific formate dehydrogenase from 
Candida metylica allows the enzyme to use NADP, Biotecnology 
Letters, 23, 283-287    
[19] Kelly, G. C., Chen, R. R., 2007. A Window into Biocatalysis and 
Biotransformations, Biotechnol. Prog., 23, 52-54     
[20]  Lamzin, V.S., Dauter, Z., Popov, V.O., Harutyunyan, E.H.,    Wilson, K.S.,  
1994. High resolution structures of holo and apo formate 
dehydrogenase,  J. Mol.Biol., 236, 759–785 
[21] Leisola, M., Turunen, O., 2007. Protein engineering: opportunities and 
challenges, Appl Microbiol Biotechnol.        
[22] Mayer, K. M., Arnold, F. H., (2002), A Colorimetric Assay to Quantify 
Dehydrogenase Activity in Crude Cell Lysates, The Society for 
Biomolecular Screening, 7: 135-140  
[23] McLachlan, M. J., Johannes, T. W., Zhao, H., 2008. Further improvement of 
phosphite dehydrogenase thermostability by saturation 
mutagenesis, Biotechnol. Bioeng., 99, 268-274  
[24] Mills, D. R., Peterson, R. L., Spiegelman, S., 1967. An extracellular 
Darwinian experiment with a self-duplicating nucleic acid 
molecule, Proc. Natl. Acad. Sci. U.S.A., 58, 217-224   
[25] Miyazaki, K., Arnold, F. H., 1999. Exploring nonnatural evolutionary 
pathways by saturation muatgenesis: rapid improvement of protein 
function, J. Mol. Evol., 49, 716-720  
  
55 
[26] Parikh, M. R., Matsumura, I., 2005. Site-saturation mutagenesis is more 
efficient than DNA shuffling for the directed evolution of β- 
Fucosidase from  β- Galactosidase, J. Mol. Biol., 352, 621-628  
[27] Pitela, S. B., Chob, C. M., Chen, W., Zhao, H., 2007. Chapter 3. Directed 
Evolution Tools in Bioproduct andBioprocess Development, 
Bioprocessing for Value-Added Products from Renewable 
Resources, 49-72  
[28] Popov, V. 0., Lamzin, V. S., 1994. NAD+-dependent formate dehydrogenase,  
Biochem. J., 301, 625-643  
[29] Que´me´ neur, E., Moutiez, M., Charbonnier, J. B., Me´ nez, A., 1998. 
Engineering cyclophilin into a proline-specific endopeptidase, 
Nature, 391, 301–304  
[30] Rubingh, D. N., 1997. Protein engineering from a bioindustrial point of view, 
Current Opinion in Biotechnology, 8, 417-422  
[31] Schirwitz, K., Schmidt, A., Lamzin, V. S., 2007. High-resolution structures of 
formate dehydrogenase from Candida boidinii, Protein Sci. 16, 
1146-1156  
[32] Seelbach, K., Riebel, B., Hummel, W., Kula, M. R., Tishkov, V., Egorov, A. 
M.,Wandrey, C., Kragl, U., 1996. A novel, efficient regenerating 
method of NADPH using a new formate dehydrogenase, 
Tetrahedron Lett.,  37, 1377–1380 
[33] Serov, A. E., Popova, A. S.,  Fedorchuk, V. V., Tishkov, V. I., 2002. 
Engineering of coenzyme specificity of formate dehydrogenase 
from Saccharomyces cerevisiae, Biochem. J., 367, 841–847  
 [35] Spadiut, O., Pisanelli, I., Maischberger, T., Peterbauer, C., Gorton, L., 
Chaiyen, P., Haltrich, D., 2008. Engineering of pyranose 2-
oxidase: Improvement for biofuel cell and food applications 
through semi-rational protein design, Journal of Biotechnology, 
139, 250–257   
[36] Stemmer, W. P., 1994. DNA shuffling by random fragmentation and 
reassembly: in vitro recombination for molecular evolution, Proc. 
Natl. Acad. Sci. U.S.A., 91, 10747-10751   
[37] Tishkov, V. I., Popov, V. O., 2004. Catalytic Mechanism and Application of 
Formate Dehydrogenase, Biochemistry, 69, 1252-1267  
[38] Tishkov, V. I.,  Popov, V. O., 2006. Protein engineering of formate 
dehydrogenase, Biomolecular Engineering, 23, 89–110  
[39] Wahler, D., Reymond, J. L., 2001. Novel methods for biocatalyst screening, 
Current Opinion in Chemical Biology, 5, 152-158  
[40] Williams, G. J., Nelson, A. S., Berry, A., 2004. Directed evolution of enzymes 
for biocatalysis and the life sciences, Cell. Mol. Life Sci., 61, 3034–
3046  
[41] Wong, T. S., Tee, K. L., Hauer, B., Schwaneberg, U., 2004. Sequence 
saturation mutagenesis (SeSaM): a novel method for directed 
evolution,  Nucleic Acids Res,  
  
56 
[42] Yoshikuni, Y., Ferrin, T. E., Keasling, J. D., 2006. Designed divergent 
evolution of enzyme function,  Nature, 440, 1078–1082   
[43] Yuan, L., Kurek, I.,  English, J., Keenan, R., Laboratory-Directed Protein 
Evolution, 2005. Microbiology and Molecular Biology Reviews, 
69, 373–392   
[44] Zhao, H., Zha, W., 2003. „„Evolutionary Methods for Protein Engineering.” In 
Enzyme Functionality: Design, Engineering and Screening, , 
Marcel Dekker, Inc., New York, NY, pp. 353-373   
[45] Rozzell, J. D., Hua, L., Mayhew, M., Novick, S., 2004. Mutants of enzymes 
and methods for their use, US Patent Application Publication, No: 
US2004/0115691 
[46] Ordu, E.B., Karagüler, N.G., 2007. Improving the purification of 
NAD
+
dependent formate dehydrogenase from Candida methylica, 
Prep. Biochem. and Biotech., 37, 333-341  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
57 
CURRICULUM VITAE                              
Candidate’s full name:   Gulsah PAR 
Place and date of birth:  Bornova/ IZMIR – 21/08/1981 
Permanent Address:       Tarabya/ ISTANBUL 
 
Universities and  
Colleges attended:           B.Sc. : Biology, Egean University (1999-2004) 
       
Publications: 
 Par, G., Yelboga, E., Ordu, E.B., Sessions, R.B., Clarke, A. R, 
Karaguler, N. G., Site-Saturation Mutagenesis of Crucial Residues in NAD 
/NADP specificity of Formate Dehydrogenase from Candida methylica, 8th 
International  ProStab Conference, poster presentation, in 2009, in Graz 
(AUSTRIA) 
 
 Karaguler, N.  G., Ordu, E., Yelboga, E., Par, G., Binay, B.,. Sessions, 
R. B.,  Clarke, A. R., Nanobiyokatalizör Geliştirilmesinde Protein 
Mühendisliği Uygulamaları, Istanbul Technical Universty, NanoScience and 
Nanotechnology Workshop, poster presentation, in 2009, in Istanbul 
(TURKEY) 
 
